Radware Software Selected by Fortune 500 Pharma Company

Cyber Security Investing

A Fortune 500 pharmaceutical firm has purchased a multi-year subscription to its cloud protection and its cloud web firewall software.

Radware (NASDAQ:RDWR) announced that a Fortune 500 pharmaceutical and life sciences firm has purchased a subscription to its cloud protection service and its cloud web firewall software in a multi-million dollar, multi-year deal.

As quoted in the press release:

Radware displaced multiple incumbent vendors in the deal after the customer opted for a single, comprehensive cloud security service that will protect the customer’s more than 20 data centers and thousands of web applications worldwide. This new customer chose Radware because of its complete cloud security offering, including global cloud DDoS and application protection, its superior technology, and its working relationship with global systems integrators that allowed it to quickly implement Radware’s cloud security services.

Click here to read the full press release.

The Conversation (0)
×